Adjuvant radiotherapy for WHO grade II meningiomas: the unanswered question - Top-Institutions - MDSpire

Adjuvant radiotherapy for WHO grade II meningiomas: the unanswered question

  • By

  • Alice Giotta Lucifero

  • Ossama Al-Mefty

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #4

    Erasmus MC Cancer Institute
    Erasmus MC Cancer Institute

    Rotterdam, Netherlands

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #5

    University Hospital of Heidelberg
    University Hospital of Heidelberg

    Heidelberg, Germany

    Key Differentiators

    • Oncology
    • Neurosurgery

Original Source(s)

Adjuvant radiotherapy for WHO grade II meningiomas: the unanswered question

  • by Alice Giotta Lucifero, Ossama Al-Mefty

  • June 24, 2026

Related Content

Advancing glioblastoma research by establishing a whole brain slice model

Outcomes of malignant orbital tumors: a 22-year Norwegian single-center series

The mechanism of action, clinical significance, and research progress of tumor antigen-specific T cells in the treatment of HCC